SA Pharmaceutical Journal - Volume 80, Issue 1, 2013
Volume 80, Issue 1, 2013
Author Lorraine OsmanSource: SA Pharmaceutical Journal 80 (2013)More Less
When making the decision to include the following ramblings about interns in A Piece of my Mind this month, I reminded myself that my job is to be diplomatic. I speak to many pharmacists; many angry pharmacists and many frustrated pharmacists. I wish I could help them all, but I canâ??t. I can listen, offer support, sometimes make a small intervention, but usually, with the best will in the world, I do not have the power to address their concerns and make things better.
Aequam memento rebus in arduisservare mentem - Horace "Remember when life's path is steep to keep your mind even." : president's messageAuthor Johann KrugerSource: SA Pharmaceutical Journal 80 (2013)More Less
By the time you read this, you will have probably been wished a healthy and prosperous year ad nauseam, but have not felt prosperity and health rain down on you. It is likely that you're a bit sceptical about the year, but at the time of writing this, the year was still fresh and brand, spanking new! There is always something exciting about a new year, a new beginning, the opportunity to do things right, to be positive in outlook and to be a huge success this time round! Well, letâ??s give it a go anyway!
Author Hayley SmithSource: SA Pharmaceutical Journal 80, pp 16 –20 (2013)More Less
Recognising nonerosive reflux disease (NERD) as a distinct presentation of gastro-oesophageal reflux disease (GORD) has been one of the most important developments in the field of GORD. Therapeutic modalities still focus on acid suppression for the management of heartburn, GORD and NERD. However, there is growing recognition that other therapeutic treatments should be considered for NERD.
Author Willie MollentzeSource: SA Pharmaceutical Journal 80, pp 22 –25 (2013)More Less
Globally, type 2 diabetes remains the most common type of diabetes, and its prevalence is rising, unabatedly driven by physical inactivity and the emerging epidemic of obesity. The risk of developing type 2 diabetes is especially increased in rural girls, of whom up to 25% are already overweight or obese in late adolescence.
Source: SA Pharmaceutical Journal 80, pp 28 –29 (2013)More Less
Sitagliptin monotherapy, or as add-on therapy, is generally well tolerated with the additional benefit of causing weight loss in patients with type 2 diabetes. Sitagliptin also has a lower potential for hypoglycaemic events because of the glucose-dependent mechanism of action.
Author Shirley-Anne BoschmansSource: SA Pharmaceutical Journal 80 (2013)More Less
Best wishes for the New Year from the Academy to all the readers of the South African Pharmaceutical Journal. As Oprah Winfrey said: "Cheers to a New Year and another chance for us to get it right." Traditionally, at the start of the New Year, we all look critically at our lives. We make resolutions to change the way in which we do things, or to start achieving things which we have not donebefore. Mostly, these resolutions pertain to personal habits, such as our eating or exercise patterns, but perhaps they should extend to our professional lives. It might be a good idea to make a few resolutions about the way in which we practice our profession.
NMMU launches new programmes, opens new facilities and celebrates excellence in pharmacy education : cum laudeAuthor Jane McCartneySource: SA Pharmaceutical Journal 80, pp 32 –33 (2013)More Less
Staff and students at Nelson Mandela Metropolitan University's (NNMU) Pharmacy Department celebrated the opening of new and upgraded facilities with a Pharmacy Day held on 17 October 2012. The R24-million revamp of the department was made possible by a grant from the Department of Higher Education.
Author Thanushya PillayeSource: SA Pharmaceutical Journal 80, pp 34 –36 (2013)More Less
It gives me great pleasure to report to the General Council of the 56th Annual General Meeting of the South African Association of Hospital and Institutional Pharmacists (SAAHIP) on the activities of the association, the National Executive Committee (NEC), and your elected President for the period March 2012 to February 2013.
Author Kobus Le RouxSource: SA Pharmaceutical Journal 80, pp 38 –39 (2013)More Less
As we begin the new year, I am encouraged by the opportunities that are unfolding for our profession, while at the same time I'm acutely aware of the challenges that together we must overcome before the full extent of the new opportunities can be realised.
In the interest of servicing our patients and the people of our country with a quality pharmaceutical service, we must urgently focus our attention on the immediate removal of obstacles, while we continue to prepare for the broader scope of practice envisaged by the Pharmacy Council.
I believe that as medicine specialists in the healthcare team, we alone carry the burden of responsibility for identifying and rooting out the hidden agendas, the politics and misguided policies that prevent everyone from receiving the benefit of the quality pharmaceutical service for which we are trained and qualified to deliver.
As we navigate our path towards delivering an improved and more comprehensive quality pharmaceutical service in our country, it is inevitable that we will encounter some stormy weather through which we will have to pass in order to reach calm seas again. I want to address some of these challenges.
Source: SA Pharmaceutical Journal 80, pp 40 –42 (2013)More Less
This is an article written by a PSSA staff member Nitsa Manolis. It has nothing to do with pharmacy. In which case, you may wonder why itâ??s been included. The reason for its insertion is because the editor is becoming increasingly aware of how important it is to have more in one's life than work. So what is your story? Please share it with us.